Successful Stem Cell Apheresis Using Spectra Optia in a 6 kg Child With Atypical Teratoid/Rhabdoid Tumor.


Journal

Journal of pediatric hematology/oncology
ISSN: 1536-3678
Titre abrégé: J Pediatr Hematol Oncol
Pays: United States
ID NLM: 9505928

Informations de publication

Date de publication:
10 2020
Historique:
pubmed: 19 2 2020
medline: 1 1 2021
entrez: 19 2 2020
Statut: ppublish

Résumé

Peripheral blood stem cell apheresis has become a routine procedure for the collection of peripheral blood stem cells to enable high-dose chemotherapy followed by autologous stem cell transplantation in high-risk pediatric malignancies. However, the procedure remains challenging in very low-weight infants due to high extracorporeal blood volume and citrate toxicity. Our case report demonstrates in detail a successful and complication-free large-volume leukapheresis in a very small infant weighing 6 kg using a Spectra Optia apheresis system after placing a femoral double-lumen Shaldon catheter. Anticoagulation was achieved by citrate dextrose solution without the use of heparin. The total amount of blood being processed during the procedure equaled almost 4 times the total blood volume of the patient. The final apheresis product contained 14.0×10 CD34 cells/kg body weight. The infant was diagnosed with an atypical teratoid/rhabdoid tumor of the thalamus and third ventricle at the age of 3 months and had a history of epileptic seizures.

Identifiants

pubmed: 32068650
doi: 10.1097/MPH.0000000000001745
pii: 00043426-202010000-00045
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e692-e695

Références

Ohara Y, Ohto H, Tasaki T, et al. Comprehensive technical and patient-care optimization in the management of pediatric apheresis for peripheral blood stem cell harvesting. Transfus Apher Sci. 2016;55:338–343.
Miano M, Labopin M, Hartmann O, et al. Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2007;39:89–99.
Lafay-Cousin L, Strother D. Current treatment approaches for infants with malignant central nervous system tumors. Oncologist. 2009;14:433–444.
Berthold F, Boos J, Burdach S, et al. Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial. Lancet Oncol. 2005;6:649–658.
Shen V, Woodbury C, Killen R, et al. Collection and use of peripheral blood stem cells in young children with refractory solid tumors. Bone Marrow Transplant. 1997;19:197–204.
Woehrer A, Slavc I, Waldhoer T, et al. Incidence of atypical teratoid/rhabdoid tumors in children: a population-based study by the Austrian Brain Tumor Registry, 1996-2006. Cancer. 2010;116:5725–5732.
Bruggers CS, Bleyl SB, Pysher T, et al. Clinicopathologic comparison of familial versus sporadic atypical teratoid/rhabdoid tumors (AT/RT) of the central nervous system. Pediatr Blood Cancer. 2011;56:1026–1031.
Frühwald M, Furtwängler R. European Rhabdoid Registry: A multinational registry for rhabdoid tumors of any anatomical site; 2016. Available at: www.kinderkrebsinfo.de/sites/kinderkrebsinfo/content/e1676/e9032/e1758/e83294/download84621/EU-RHABProtokollStand08.12.2016_ger.pdf. Accessed February 4, 2019.
Meyer EK, Wong ECC. Pediatric therapeutic apheresis: a critical appraisal of evidence. Transfus Med Rev. 2016;30:217–222.
Cooling L, Hoffmann S, Webb D, et al. Procedure-related complications and adverse events associated with pediatric autologous peripheral blood stem cell collection. J Clin Apher. 2017;32:35–48.
Hegde V, Setia R, Soni S, et al. Prophylactic low dose continuous calcium infusion during peripheral blood stem cell (PBSC) collections to reduce citrate related toxicity. Transfus Apher Sci. 2016;54:373–376.
Alex J, Bahl MJ, Schlueter AJ. Peripheral blood stem cell recovery following early termination of apheresis due to hypotension in a 4.8-kg infant. J Clin Apher. 2009;24:120–121.
Bojanic I, Mazic S, Rajic L, et al. Large volume leukapheresis is efficient and safe even in small children up to 15 kg body weight. Blood Transfus. 2017;15:85–92.
Abrahamsen JF, Stamnesfet S, Liseth K, et al. Large-volume leukapheresis yields more viable CD34+ cells and colony-forming units than normal-volume leukapheresis, especially in patients who mobilize low numbers of CD34+ cells. Transfusion. 2005;45:248–253.
Karakukcu M, Unal E. Stem cell mobilization and collection from pediatric patients and healthy children. Transfus Apher Sci. 2015;53:17–22.
Liao YM, Yeh CJ, Shu HL, et al. Successful large-volume leukapheresis for hematopoietic stem cell collection in a very-low-weight brain tumor infant with coagulopathy. Pediatr Neonatol. 2013;54:211–213.
Ge X, Cavallazzi R, Li C, et al. Central venous access sites for the prevention of venous thrombosis, stenosis and infection. Cochrane Database Syst Rev. 2012;14:CD004084.
Gidwani P, Levy A, Goodrich J, et al. Successful outcome with tandem myeloablative chemotherapy and autologous peripheral blood stem cell transplants in a patient with atypical teratoid/rhabdoid tumor of the central nervous system. J Neurooncol. 2008;88:211–215.
Yano S, Hida K, Kobayashi H, et al. Successful multimodal therapies for a primary atypical teratoid/rhabdoid tumor in the cervical spine. Pediatr Neurosurg. 2008;44:406–413.
Zaky W, Dhall G, Ji L, et al. Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience. Pediatr Blood Cancer. 2014;61:95–101.
Schrey D, Carceller Lechón F, Malietzis G, et al. Multimodal therapy in children and adolescents with newly diagnosed atypical teratoid rhabdoid tumor: individual pooled data analysis and review of the literature. J Neurooncol. 2016;126:81–90.

Auteurs

Patrick Brust (P)

Clinic of Pediatric Oncology and Hematology.
University Medical Center Hamburg-Eppendorf, University Children's Hospital, Hamburg, Germany.

Claudia Schubert (C)

Department of Transfusion Medicine, University Medical Center Hamburg-Eppendorf.

Martin Blohm (M)

University Medical Center Hamburg-Eppendorf, University Children's Hospital, Hamburg, Germany.

Beate Winkler (B)

Clinic of Pediatric Oncology and Hematology.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH